The University of Tartu and India’s biggest medical technology company, Trivitron Healthcare Pvt Ltd, signed a memorandum of understanding, forming the basis of a broad scientific cooperation and furthering of medical education between India and Estonia.
The cooperation will mainly be launched in areas related to mass spectrometry, microchips, sequencing, molecular diagnostics and biobanking. “The University of Tartu holds a leading position in the area of health care and medicine in Estonia and in the Baltic Sea region. The university’s competence and means for innovative research and development activities were the reasons that motivated the major Indian enterprise to cooperate with the University of Tartu,” said Erik Puura, Vice-Rector for Development of the university.
The cooperation will begin when the partners have decided on common topics that are of interest to the researchers while also having commercial potential. “Our aim is to initiate contacts between employees with similar interests to exchange the newest knowledge and develop solutions furthering people’s health,” Jane Luht, head of technology transfer at the University of Tartu said, adding that exchange has already been initiated between four working groups.
The partners will also explore the opportunities to establish an educational centre for the university in India, Dubai or Shanghai, affiliated to Trivitron, and together promote medical education programs of the University of Tartu among Asian students.
According to the university, Trivitron is India’s leading medical technology company, being the biggest manufacturer and marketer of equipment for cardiology and implantable devices, in vitro diagnostics, imaging, intensive care and operating room space as well as a leader in the development of ophthalmology, renal and intensive care. The company operates globally in the name of innovation and cooperation to make health care accessible and affordable to the developed and emerging markets.
I
Cover photo: Science Centre Ahhaa in Tartu. Photo by Arne Maasik.